EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Donepezil Research in Cognitive Impairment: A Bibliometric and Scientometric Analysis of Global Trends and Pharmacological Perspectives

Wencai Wang, Yinuo Chen, Zijie Xiong, Zun Wang, Wei Ye, Xianfeng Li

Brain and Behavior · 2026

DOI: 10.1002/brb3.71251 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain and Behavior, 2026. Verfasst von Wencai Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Bibliometrics, Cholinesterase Inhibitors, Cognitive Dysfunction, Donepezil. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Neurosurgery First-class Discipline Funding Project of the Second Affiliated Hospital of Harbin Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cognitive impairment (CI) greatly affects global health and quality of life. Donepezil, a widely used treatment for CI, particularly in Alzheimer's disease, has been extensively studied; however, a comprehensive bibliometric analysis summarizing global research trends remains limited.

Methods

Relevant English‐language articles and reviews published between 2000 and 2025 were retrieved from the Web of Science Core Collection. CiteSpace and VOSviewer were employed to analyze publication trends, collaborative networks, journal distribution, co‐citation patterns, and keyword co‐occurrence.

Results

A total of 1907 publications were identified. The United States led in both output and citation impact, with the University of Toronto emerging as the most influential institution. The U.S. Department of Health and Human Services provided the greatest funding support. The Journal of Alzheimer's Disease was the primary publishing outlet, and Etsuro Mori was the most prolific and influential author. Keyword analysis revealed “Donepezil,” “Alzheimer's disease,” and “Mild cognitive impairment” as dominant terms. Recent hotspots—such as “acetylcholinesterase,” “oxidative stress,” “neuroinflammation,” “tau protein,” and “mechanism”—reflect a shift toward mechanistic and preclinical research.

Conclusion

Research on donepezil for CI has shown consistent growth, evolving from clinical application toward mechanistic exploration and disease modification. Future studies are expected to focus on individualized therapy, combination strategies, and underexplored CI subtypes, aiming to enhance the therapeutic potential and clinical value of donepezil.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BibliometricsCholinesterase InhibitorsCognitive DysfunctionDonepezilNootropic AgentsHumansAlzheimer Disease

Stichwörter der Autor:innen

Scientometric AnalysisWeb of Science Core Collectionbibliometric analysiscognitive impairmentdonepezilknowledge graph analyses

Substanzen

Cholinesterase InhibitorsDonepezilNootropic Agents

Autor:innen und Institutionen

  • Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.

Förderung

  • Neurosurgery First-class Discipline Funding Project of the Second Affiliated Hospital of Harbin Medical University

Zitieren

APA

Wang, W., Chen, Y., Xiong, Z., Wang, Z., Ye, W., & Li, X. (2026). Donepezil Research in Cognitive Impairment: A Bibliometric and Scientometric Analysis of Global Trends and Pharmacological Perspectives. Brain and Behavior. https://doi.org/10.1002/brb3.71251

Vancouver

Wang W, Chen Y, Xiong Z, Wang Z, Ye W, Li X. Donepezil Research in Cognitive Impairment: A Bibliometric and Scientometric Analysis of Global Trends and Pharmacological Perspectives. Brain and Behavior. 2026. doi:10.1002/brb3.71251

BibTeX
@article{Wang2026,
  author = {Wang, Wencai and Chen, Yinuo and Xiong, Zijie and Wang, Zun and Ye, Wei and Li, Xianfeng},
  title = {Donepezil Research in Cognitive Impairment: A Bibliometric and Scientometric Analysis of Global Trends and Pharmacological Perspectives},
  journal = {Brain and Behavior},
  year = {2026},
  doi = {10.1002/brb3.71251}
}
Kostenlos starten →